TerrAscend (TSNDF) Operating Income (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Operating Income of $11.5 million for Q1 2026, down 5.9% year-over-year from $12.2 million in Q1 2025, and up 50.31% quarter-over-quarter from $7.7 million in Q4 2025.
TerrAscend (TSNDF) Operating Income (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Operating Income for 6 consecutive years, with $11.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 5.9% year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $41.3 million (down 1.21% YoY), while the FY2025 annual figure was $42.0 million, up 7.96% from the prior year.
- Operating Income improved to $11.5 million in Q1 2026 per TSNDF's latest filing, from $7.7 million in the prior quarter.
- Across five years, Operating Income topped out at $17.7 million in Q3 2023 and bottomed at -$330.1 million in Q3 2022.
- Historically, Operating Income has averaged -$12.8 million across 5 years, with a median of $7.7 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Income slumped 18550.56% — and 2024, when it soared 204.12%.
- TerrAscend's Operating Income stood at $13.7 million in 2022, then sank by 65.69% to $4.7 million in 2023, then surged by 147.7% to $11.7 million in 2024, then sank by 34.31% to $7.7 million in 2025, then soared by 50.31% to $11.5 million in 2026.
- Business Quant data shows TSNDF's Operating Income at $11.5 million in Q1 2026, $7.7 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 12.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.11 Mn |
| Mar 31, 2026 | 11.52 Mn |
| Dec 31, 2025 | 7.67 Mn |
| Sep 30, 2025 | 11.14 Mn |
| Jun 30, 2025 | 10.97 Mn |
| Mar 31, 2025 | 12.24 Mn |
| Dec 31, 2024 | 11.67 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 13.73 Mn |
| Sep 30, 2022 | -330.12 Mn |
| Jun 30, 2022 | -11.56 Mn |
| Mar 31, 2022 | -7.98 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Sep 30, 2021 | -1.77 Mn |